Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect

Abstract Background Sepsis involves life-threatening organ dysfunction and is caused by a dysregulated host response to infection. No specific therapies against sepsis have been reported. Celastrol (Cel) is a natural anti-inflammatory compound that shows potential against systemic inflammatory disea...

Full description

Bibliographic Details
Main Authors: Piao Luo, Qian Zhang, Tian-Yu Zhong, Jia-Yun Chen, Jun-Zhe Zhang, Ya Tian, Liu-Hai Zheng, Fan Yang, Ling-Yun Dai, Chang Zou, Zhi-Jie Li, Jing-Hua Liu, Ji-Gang Wang
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Military Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40779-022-00381-4
_version_ 1811256741831114752
author Piao Luo
Qian Zhang
Tian-Yu Zhong
Jia-Yun Chen
Jun-Zhe Zhang
Ya Tian
Liu-Hai Zheng
Fan Yang
Ling-Yun Dai
Chang Zou
Zhi-Jie Li
Jing-Hua Liu
Ji-Gang Wang
author_facet Piao Luo
Qian Zhang
Tian-Yu Zhong
Jia-Yun Chen
Jun-Zhe Zhang
Ya Tian
Liu-Hai Zheng
Fan Yang
Ling-Yun Dai
Chang Zou
Zhi-Jie Li
Jing-Hua Liu
Ji-Gang Wang
author_sort Piao Luo
collection DOAJ
description Abstract Background Sepsis involves life-threatening organ dysfunction and is caused by a dysregulated host response to infection. No specific therapies against sepsis have been reported. Celastrol (Cel) is a natural anti-inflammatory compound that shows potential against systemic inflammatory diseases. This study aimed to investigate the pharmacological activity and molecular mechanism of Cel in models of endotoxemia and sepsis. Methods We evaluated the anti-inflammatory efficacy of Cel against endotoxemia and sepsis in mice and macrophage cultures treated with lipopolysaccharide (LPS). We screened for potential protein targets of Cel using activity-based protein profiling (ABPP). Potential targets were validated using biophysical methods such as cellular thermal shift assays (CETSA) and surface plasmon resonance (SPR). Residues involved in Cel binding to target proteins were identified through point mutagenesis, and the functional effects of such binding were explored through gene knockdown. Results Cel protected mice from lethal endotoxemia and improved their survival with sepsis, and it significantly decreased the levels of pro-inflammatory cytokines in mice and macrophages treated with LPS (P < 0.05). Cel bound to Cys424 of pyruvate kinase M2 (PKM2), inhibiting the enzyme and thereby suppressing aerobic glycolysis (Warburg effect). Cel also bound to Cys106 in high mobility group box 1 (HMGB1) protein, reducing the secretion of inflammatory cytokine interleukin (IL)-1β. Cel bound to the Cys residues in lactate dehydrogenase A (LDHA). Conclusion Cel inhibits inflammation and the Warburg effect in sepsis via targeting PKM2 and HMGB1 protein.
first_indexed 2024-04-12T17:45:52Z
format Article
id doaj.art-1b598b7ec7c04be6ac1055d971c085d7
institution Directory Open Access Journal
issn 2054-9369
language English
last_indexed 2024-04-12T17:45:52Z
publishDate 2022-05-01
publisher BMC
record_format Article
series Military Medical Research
spelling doaj.art-1b598b7ec7c04be6ac1055d971c085d72022-12-22T03:22:40ZengBMCMilitary Medical Research2054-93692022-05-019111610.1186/s40779-022-00381-4Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effectPiao Luo0Qian Zhang1Tian-Yu Zhong2Jia-Yun Chen3Jun-Zhe Zhang4Ya Tian5Liu-Hai Zheng6Fan Yang7Ling-Yun Dai8Chang Zou9Zhi-Jie Li10Jing-Hua Liu11Ji-Gang Wang12Artemisinin Research Center, and Institute of Chinese Materia Medica, Chinese Academy of Chinese Medical SciencesArtemisinin Research Center, and Institute of Chinese Materia Medica, Chinese Academy of Chinese Medical SciencesLaboratory Medicine, the First Affiliated Hospital of Gannan Medical UniversityArtemisinin Research Center, and Institute of Chinese Materia Medica, Chinese Academy of Chinese Medical SciencesArtemisinin Research Center, and Institute of Chinese Materia Medica, Chinese Academy of Chinese Medical SciencesArtemisinin Research Center, and Institute of Chinese Materia Medica, Chinese Academy of Chinese Medical SciencesDepartment of Geriatric Medicine, Shenzhen People’s Hospital, the Second Clinical Medical College, Jinan University and the First Affiliated Hospital, Southern University of Science and TechnologyDepartment of Geriatric Medicine, Shenzhen People’s Hospital, the Second Clinical Medical College, Jinan University and the First Affiliated Hospital, Southern University of Science and TechnologyDepartment of Geriatric Medicine, Shenzhen People’s Hospital, the Second Clinical Medical College, Jinan University and the First Affiliated Hospital, Southern University of Science and TechnologyGuangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical UniversityDepartment of Geriatric Medicine, Shenzhen People’s Hospital, the Second Clinical Medical College, Jinan University and the First Affiliated Hospital, Southern University of Science and TechnologyGuangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical UniversityArtemisinin Research Center, and Institute of Chinese Materia Medica, Chinese Academy of Chinese Medical SciencesAbstract Background Sepsis involves life-threatening organ dysfunction and is caused by a dysregulated host response to infection. No specific therapies against sepsis have been reported. Celastrol (Cel) is a natural anti-inflammatory compound that shows potential against systemic inflammatory diseases. This study aimed to investigate the pharmacological activity and molecular mechanism of Cel in models of endotoxemia and sepsis. Methods We evaluated the anti-inflammatory efficacy of Cel against endotoxemia and sepsis in mice and macrophage cultures treated with lipopolysaccharide (LPS). We screened for potential protein targets of Cel using activity-based protein profiling (ABPP). Potential targets were validated using biophysical methods such as cellular thermal shift assays (CETSA) and surface plasmon resonance (SPR). Residues involved in Cel binding to target proteins were identified through point mutagenesis, and the functional effects of such binding were explored through gene knockdown. Results Cel protected mice from lethal endotoxemia and improved their survival with sepsis, and it significantly decreased the levels of pro-inflammatory cytokines in mice and macrophages treated with LPS (P < 0.05). Cel bound to Cys424 of pyruvate kinase M2 (PKM2), inhibiting the enzyme and thereby suppressing aerobic glycolysis (Warburg effect). Cel also bound to Cys106 in high mobility group box 1 (HMGB1) protein, reducing the secretion of inflammatory cytokine interleukin (IL)-1β. Cel bound to the Cys residues in lactate dehydrogenase A (LDHA). Conclusion Cel inhibits inflammation and the Warburg effect in sepsis via targeting PKM2 and HMGB1 protein.https://doi.org/10.1186/s40779-022-00381-4CelastrolSepsisPyruvate kinase M2High mobility group box 1Aerobic glycolysis
spellingShingle Piao Luo
Qian Zhang
Tian-Yu Zhong
Jia-Yun Chen
Jun-Zhe Zhang
Ya Tian
Liu-Hai Zheng
Fan Yang
Ling-Yun Dai
Chang Zou
Zhi-Jie Li
Jing-Hua Liu
Ji-Gang Wang
Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
Military Medical Research
Celastrol
Sepsis
Pyruvate kinase M2
High mobility group box 1
Aerobic glycolysis
title Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
title_full Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
title_fullStr Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
title_full_unstemmed Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
title_short Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
title_sort celastrol mitigates inflammation in sepsis by inhibiting the pkm2 dependent warburg effect
topic Celastrol
Sepsis
Pyruvate kinase M2
High mobility group box 1
Aerobic glycolysis
url https://doi.org/10.1186/s40779-022-00381-4
work_keys_str_mv AT piaoluo celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT qianzhang celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT tianyuzhong celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT jiayunchen celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT junzhezhang celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT yatian celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT liuhaizheng celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT fanyang celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT lingyundai celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT changzou celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT zhijieli celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT jinghualiu celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect
AT jigangwang celastrolmitigatesinflammationinsepsisbyinhibitingthepkm2dependentwarburgeffect